Anyone who does not believe in this company now should not be investing in biotechs. With the deal with Hovione, the Zafirulkast programme is totally de-risked. The drug has been proven safe and effective in previous trials. It was only awaiting a suitable formulation when the previous propellant (cfc) was banned. Hovione will provide that. The latest results for Cpn10, along with extensive results from previous trials, notwithstanding the very poor design of those trials, are at least sufficient for the major cost of further development being accepted by other drug companies. The latest trial results completely underwrite the hypothesis Invion (and their academic collaborators) have proposed around Nadolol. It is all speed ahead for an oral smoking cessation drug. Given the legal problems Pfizer is having with their "standard of care" drug at the moment, I would say that they cannot let this pass into the hands of any other party. The inhaled programme is totally underwritten. Any reasonable valuation would come in above $2.
- Forums
- ASX - By Stock
- IVX
- Ann: Invion - successful completion of P2 study of INV102
Ann: Invion - successful completion of P2 study of INV102, page-8
-
- There are more pages in this discussion • 78 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IVX (ASX) to my watchlist
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.33M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.2¢ | $6.251K | 2.967M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
47 | 43316984 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 4352691 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
47 | 43316984 | 0.002 |
26 | 29577144 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 4352691 | 8 |
0.004 | 8453485 | 11 |
0.005 | 8422572 | 26 |
0.006 | 2074992 | 8 |
0.007 | 1562000 | 4 |
Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
Featured News
IVX (ASX) Chart |